FDA Opens Ninety-Day Comment Window on CRISPR Safety Framework
Comments on the FDA's first genome-editing off-target safety guidance close July 14; the four listed gene-editing firms have said nothing.
Kenji Nakamura
Bureau: Tokyo
Japan's Natural Population Decline Widens to Nearly 900,000
Japan recorded 705,809 births against 1.6 million deaths in 2025 — a natural decline of 899,845, the largest on record.
ThermoCas9 Reads Methylation Like an Address and Cuts Only Tumor Cells
A bacterium from a Wageningen compost heap turned out to carry the first CRISPR enzyme that can tell a tumor cell from a healthy one by its chemistry.
Neural Crest Cells Commit to Their Jobs Weeks Before the Textbook Says They Should
A CRISPR lineage-tracing paper from Utah and UC San Diego rewrites a basic page of developmental biology — and the childhood cancers it implicates look different in that light.